Other Diseases

Adapsyn signed a USD 162 million deal with Pfizer for microbe-mining project Adapsyn has recently signed a deal with Pfizer for the microbe-mining with the help of advance platform developed by the Canadian company adapsyn. The technique offers a quick filter for promising candidates with better efficacy. Due to the high efficiency of this technique, the big pharma Pfizer grabbed the opportunity allocated $162 million for a project that will use Adapsyn’s microbe-mining platform to search through its vast collection of microbial strains. Evolus just filed for USD 75 million IPO to bring Botox biosimilar into market To bring botox biosimilar into the market Evolus has f...